These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 23920422

  • 1. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [Abstract] [Full Text] [Related]

  • 2. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y, Miki M, Tabata T.
    Sleep Med; 2016 Oct; 27-28():45-48. PubMed ID: 27938918
    [Abstract] [Full Text] [Related]

  • 3. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 4. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, Yee BJ, Grunstein RR, Marshall NS.
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [Abstract] [Full Text] [Related]

  • 5. Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients.
    Sun H, MacLeod C, Mostoller K, Mahon C, Han L, Renger JJ, Ma J, Brown KR, Schulz V, Kay GG, Herring WJ, Lines C, Rosen LB, Murphy MG, Wagner JA.
    J Clin Pharmacol; 2013 Dec; 53(12):1294-302. PubMed ID: 24122944
    [Abstract] [Full Text] [Related]

  • 6. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y, Takasaki Y, Yamashiro Y.
    J Clin Sleep Med; 2013 Aug 15; 9(8):751-7. PubMed ID: 23946704
    [Abstract] [Full Text] [Related]

  • 8. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 9. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
    Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ.
    Am J Respir Crit Care Med; 2001 Mar 15; 163(4):918-23. PubMed ID: 11282766
    [Abstract] [Full Text] [Related]

  • 10. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.
    Respir Med; 2007 Mar 15; 101(3):616-27. PubMed ID: 16908126
    [Abstract] [Full Text] [Related]

  • 11. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE, Hirshkowitz M.
    Sleep; 2005 Apr 15; 28(4):464-71. PubMed ID: 16171291
    [Abstract] [Full Text] [Related]

  • 12. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S, Khalid M, Tulaimat A.
    J Clin Sleep Med; 2015 Oct 15; 11(10):1179-86. PubMed ID: 25979103
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan 15; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 14. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI, Black JE, Schwartz JR, Matheson JK.
    Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1675-81. PubMed ID: 11719309
    [Abstract] [Full Text] [Related]

  • 15. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 01; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 16. Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers.
    Iannone R, Palcza J, Renger JJ, Calder N, Cerchio K, Gottesdiener K, Hargreaves R, Dijk DJ, Boyle J, Murphy MG.
    Clin Pharmacol Ther; 2010 Dec 01; 88(6):831-9. PubMed ID: 20981000
    [Abstract] [Full Text] [Related]

  • 17. Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial.
    Williams SC, Marshall NS, Kennerson M, Rogers NL, Liu PY, Grunstein RR.
    Am J Respir Crit Care Med; 2010 Apr 15; 181(8):825-31. PubMed ID: 20056901
    [Abstract] [Full Text] [Related]

  • 18. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y, Verbraecken J, Partinen M, Hedner J, Saaresranta T, Georgiev O, Tiholov R, Lecomte I, Tamisier R, Lévy P, Scart-Gres C, Lecomte JM, Schwartz JC, Pépin JL, HAROSA II Study Group collaborators.
    Am J Respir Crit Care Med; 2020 May 01; 201(9):1135-1145. PubMed ID: 31917607
    [Abstract] [Full Text] [Related]

  • 19. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug 01; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 20. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
    Czeisler CA, Walsh JK, Roth T, Hughes RJ, Wright KP, Kingsbury L, Arora S, Schwartz JR, Niebler GE, Dinges DF, U.S. Modafinil in Shift Work Sleep Disorder Study Group.
    N Engl J Med; 2005 Aug 04; 353(5):476-86. PubMed ID: 16079371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.